Literature DB >> 26079975

Schmallenberg Virus Recurrence, Germany, 2014.

Kerstin Wernike, Bernd Hoffmann, Franz J Conraths, Martin Beer.   

Abstract

Schmallenberg virus (SBV) emerged in Germany in 2011, spread rapidly across Europe, and almost disappeared in 2013. However, since late summer 2014, new cases have occurred in adult cattle. Full-genome analysis revealed some amino acid substitution differences from the first SBV sample. Viremia developed in experimentally infected sheep and cattle for 4-6 days.

Entities:  

Keywords:  Germany; Schmallenberg virus; cattle; experimental infection; genetics; orthobunyavirus; phylogeny; ruminants; vector-borne infections; viruses

Mesh:

Year:  2015        PMID: 26079975      PMCID: PMC4480399          DOI: 10.3201/eid2107.150180

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Schmallenberg virus (SBV), an insect-transmitted orthobunyavirus with a negative-stranded tripartite RNA genome, causes no or only mild nonspecific clinical signs for a few days in adult ruminants (). However, infection of immunologically naive animals during a vulnerable period of pregnancy can cause premature birth, stillbirth, or severe malformations in the offspring (). SBV was first detected in autumn 2011 in the blood of an acutely infected cow in North Rhine-Westphalia, Germany (). In early 2012, a large number of malformed lambs and calves, which tested positive for SBV, were born in central Europe (). The malformations resulted from infection of the dams in summer or autumn 2011 and transplacental transmission. Within this first vector season, the virus spread rapidly within and between the animal holdings. In the center of the epidemic in northwestern Germany, the Netherlands, and Belgium, >90% of tested cattle became seropositive (). During the following year, SBV circulated again in Germany () but at a much lower level and predominantly at the margin of the initially most affected area because susceptible animals had remained there. During the 2013 vector season and the following winter, SBV cases were detected only sporadically (only SBV genome detections without successful virus isolation) (). For example, only 7 cases of viral genome detection were reported to the German Animal Disease Reporting System during January 1–March 24, 2014; these cases resulted from infection of the respective dams during summer or autumn 2013. The high seroprevalence of the ruminant population and the marked decline of births with SBV-associated malformations in newborns raised hopes that SBV had disappeared after the first epidemic, as occurred with the transient appearance of bluetongue virus serotype 8 in the same region of Europe ().

The Study

Surprisingly, during summer and autumn 2014, SBV reappeared in Germany to a greater extent. Viral genome was repeatedly detected in acutely infected cattle. Several samples from various federal states were submitted to the Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health (Insel Riems, Germany), to confirm an SBV infection (Table) and to further characterize these reemerging viruses.
Table

Origin of Schmallenberg virus real-time reverse transcription PCR–positive samples submitted to the Friedrich-Loeffler-Institut, Germany, 2014

Submission dateFederal stateNo. samplesQuantification cycle value
Sep 25Lower Saxony325.1–28.1
Sep 29Lower Saxony126.2
Oct 13North Rhine-Westphalia130.1
Oct 21Lower Saxony424.1–29.9
Oct 22North Rhine-Westphalia229.7–30.6
Oct 22North Rhine-Westphalia131.1
Oct 22Saxony-Anhalt122.8
Oct 23Saxony1424.1–29.1
Nov 4Rhineland-Palatinate427.7–38.3
Nov 11Lower Saxony126.1
To evaluate sequence variations among SBV variants circulating in Germany since 2011, the original SBV isolate (BH80/11) and viruses isolated in 2012 from the blood of viremic sheep (BH619/12) or cattle (D495/12-1 and BH652/12) were compared with 3 genomes obtained from the viruses in acutely infected adult cattle in 2014 (BH119/14-1/2, BH119/14-3/4, BH132/14). RNA was extracted by using the QIAamp Viral RNA Mini Kit (QIAGEN, Hilden, Germany) according to the manufacturer’s recommendations, and the open reading frames of all 3 genome segments (large [L], medium [M], and small [S] segment; primer sequences available on request) were sequenced as described (). Sequences generated in the current study were submitted to GenBank (accession nos. KP731865–KP731882). Sequence alignments and translation in amino acids were supported by Geneious version 7.1 (Biomatters, Auckland, New Zealand). We generated a maximum-likelihood tree (Hasegawa-Kishino-Yano model, 1,000 bootstrap replicates) using MEGA5 (). For the phylogenetic analysis of the M segment, sequences previously obtained from organ samples from newborns malformed because of SBV infection also were integrated (). For the S segment (830-nt long), which encodes the nucleocapsid protein (N) and a nonstructural protein (NSs), sequence analysis revealed very high stability. The samples obtained from acutely infected animals in 2014, BH619/12 and BH652/12, were 100% identical to the original SBV strain BH80/11 from 2011. In the sample D495/12-1 from 2012, a single nucleotide was substituted (Technical Appendix Figure). The viral RNA-dependent RNA polymerase encoding L segment (6864 nt) also showed high stability, and only a few nucleotide substitutions compared with BH80/11 were found in the latest samples (D495/12-1 and BH652/12: 6 nt; BH619/12: 10 nt; BH119/14-1/2, BH119/14-3/4. and BH132/14: 18 nt). Overall, sequence identity was 99.7%–99.9% (Technical Appendix Figure). Nonsynonymous substitutions ranged from 1 aa to 4 aa (Technical Appendix Figure). The M segment (4415-nt long) encodes 2 glycoproteins (Gn and Gc) and a nonstructural protein (NSm). It is the most variable genome segment of SBV and related viruses (,,). Despite the identification of a highly variable region within the Gc-coding sequence in viruses in malformed newborns (,), there was a high sequence stability of the viruses detected in the blood of acutely infected adult animals; all sequences clustered closely (Figure 1). In contrast to the maximum of 77 nt and 43 aa substitutions or 12 aa deletions or 2 aa insertions found in organ samples of lambs or calves (), we detected only 6–12 nt and 2 aa (BH619/12), 3 aa (D495/12-1, BH119/14-3/4, BH132/14) or 4 aa (BH652/12, BH119/14-1/2) substitutions (Technical Appendix Figure). Because Gn and Gc are major immunogens of orthobunyaviruses (), the mutation hot spot was supposed to be involved in immune evasion mechanisms and/or adaption of the cell tropism within the individual host (,). However, insect-transmitted viruses such as SBV have to adapt to 2 hosts and undergo replication cycles in both the arthropod vector and the mammalian host. Thus, the high sequence stability of virus strains detectable in viremic animals might be necessary for transmission to the vector. Notably, in comparison with the original SBV isolate, K→E substitutions at aa 746 and 1340 of the M segment were found in all other samples. Because these mutations have now been consistently present for at least 2 years, they might have occurred during the adaptation to European ruminants or insects and could provide a growth advantage within the individual host or might be beneficial for transmission between host and vector.
Figure 1

Phylogenetic analysis based on nucleotide sequences of the medium segment of Schmallenberg virus samples isolated from blood of acutely infected animals in 2011 or 2012 (blue) or sequenced directly from the blood of viremic cattle in 2014 (red) and from organ samples of malformed newborns (black) (). Scale bar indicates nucleotide substitutions per site.

Phylogenetic analysis based on nucleotide sequences of the medium segment of Schmallenberg virus samples isolated from blood of acutely infected animals in 2011 or 2012 (blue) or sequenced directly from the blood of viremic cattle in 2014 (red) and from organ samples of malformed newborns (black) (). Scale bar indicates nucleotide substitutions per site. To investigate whether the detected sequence variations correlated with any change in pathogenicity, 5 female sheep and 1 female calf were subcutaneously inoculated with pools of up to 5 serum or whole blood samples from 1 of the holdings with new cases confirmed in 2014 (sheep 1 and 3 and the calf with samples from Lower Saxony; sheep 2, 4, and 5 with samples from Saxony [permit no. LALLF-M-V/TSD/7221.3–1.1–004/12]). None of the animals showed fever or any other clinical sign. Blood samples were taken daily for the first 2 weeks after inoculation and analyzed by real-time reverse transcription PCR (). Thereafter, serum samples were taken in weekly intervals and tested in a microneutralization assay () and a commercially available SBV antibody ELISA (ID Screen Schmallenberg Virus Competition; IDvet, Grabels, France). The calf and sheep 2–5 became infected; viral genome was detectable in their blood for 4–6 days (Figure 2), which agrees with the short-lived viremia previously observed after experimental infection of cattle and sheep with the original SBV sample or the first cell culture isolate (,). Antibodies were first detected on day 7 after infection (sheep 2, sheep 5) or day 14 after infection (calf, sheep 3, sheep 4) in both tests.
Figure 2

Detection of Schmallenberg virus genome in the blood of experimentally infected cattle and sheep, Germany, 2014.

Detection of Schmallenberg virus genome in the blood of experimentally infected cattle and sheep, Germany, 2014.

Conclusions

SBV, first detected in 2011, circulated again in Germany in 2014. Virus genome with a high sequence identity to the first SBV sample was repeatedly detected in the blood of acutely infected adult cattle, and in experimentally infected animals, viremia developed that was identical to the original SBV isolate. The renewed virus circulation during the 2014 vector season was observed primarily in an area less affected in the 2 previous years. The missing or markedly reduced virus circulation led to a decline in herd seroprevalence caused by a missing infection of the young stock (,); further reasons for the unexpected recurrence of SBV could be persistence within the insect vectors. As a consequence, the infection of naive animals in autumn 2014 resulted in an increasing frequency of the birth of malformed offspring in the following winter. Technical Appendix. Comparison of the small-, medium-, and large-segment sequences of Schmallenberg viruses isolated in 2012 from the blood of viremic ruminants or detected in 2014 in acutely infected adult cattle with the first SBV isolate from 2011, Germany.
  14 in total

1.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.

Authors:  Koichiro Tamura; Daniel Peterson; Nicholas Peterson; Glen Stecher; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2011-05-04       Impact factor: 16.240

2.  A mutation 'hot spot' in the Schmallenberg virus M segment.

Authors:  Melina Fischer; Bernd Hoffmann; Katja V Goller; Dirk Höper; Kerstin Wernike; Martin Beer
Journal:  J Gen Virol       Date:  2013-01-30       Impact factor: 3.891

3.  In vivo and in vitro identification of a hypervariable region in Schmallenberg virus.

Authors:  Damien Coupeau; François Claine; Laetitia Wiggers; Nathalie Kirschvink; Benoît Muylkens
Journal:  J Gen Virol       Date:  2013-01-30       Impact factor: 3.891

4.  Organ distribution of Schmallenberg virus RNA in malformed newborns.

Authors:  S Bilk; C Schulze; M Fischer; M Beer; A Hlinak; B Hoffmann
Journal:  Vet Microbiol       Date:  2012-03-30       Impact factor: 3.293

5.  Oral exposure, reinfection and cellular immunity to Schmallenberg virus in cattle.

Authors:  Kerstin Wernike; Michael Eschbaumer; Horst Schirrmeier; Ulrike Blohm; Angele Breithaupt; Bernd Hoffmann; Martin Beer
Journal:  Vet Microbiol       Date:  2013-02-07       Impact factor: 3.293

6.  Genetic diversity and reassortments among Akabane virus field isolates.

Authors:  Takahiko Kobayashi; Tohru Yanase; Makoto Yamakawa; Tomoko Kato; Kazuo Yoshida; Tomoyuki Tsuda
Journal:  Virus Res       Date:  2007-07-30       Impact factor: 3.303

Review 7.  Potential strategies for control of bluetongue, a globally emerging, Culicoides-transmitted viral disease of ruminant livestock and wildlife.

Authors:  N James Maclachlan; Christie E Mayo
Journal:  Antiviral Res       Date:  2013-05-09       Impact factor: 5.970

8.  Novel orthobunyavirus in Cattle, Europe, 2011.

Authors:  Bernd Hoffmann; Matthias Scheuch; Dirk Höper; Ralf Jungblut; Mark Holsteg; Horst Schirrmeier; Michael Eschbaumer; Katja V Goller; Kerstin Wernike; Melina Fischer; Angele Breithaupt; Thomas C Mettenleiter; Martin Beer
Journal:  Emerg Infect Dis       Date:  2012-03       Impact factor: 6.883

Review 9.  'Schmallenberg virus'--a novel orthobunyavirus emerging in Europe.

Authors:  M Beer; F J Conraths; W H M van der Poel
Journal:  Epidemiol Infect       Date:  2012-10-10       Impact factor: 4.434

10.  Reemerging Schmallenberg virus infections, Germany, 2012.

Authors:  Franz J Conraths; Doris Kämer; Kathrin Teske; Bernd Hoffmann; Thomas C Mettenleiter; Martin Beer
Journal:  Emerg Infect Dis       Date:  2013-03       Impact factor: 6.883

View more
  20 in total

1.  Genetic characterization of Italian field strains of Schmallenberg virus based on N and NSs genes.

Authors:  Francesca Izzo; Gian Mario Cosseddu; Andrea Polci; Federica Iapaolo; Chiara Pinoni; Andrea Capobianco Dondona; Fabrizia Valleriani; Federica Monaco
Journal:  Virus Genes       Date:  2016-04-08       Impact factor: 2.332

2.  Characterization of Shuni viruses detected in Israel.

Authors:  Natalia Golender; Kerstin Wernike; Velizar Bumbarov; Andrea Aebischer; Alexander Panshin; Maria Jenckel; Yevgeny Khinich; Martin Beer
Journal:  Virus Genes       Date:  2016-08-19       Impact factor: 2.332

3.  A broad spectrum screening of Schmallenberg virus antibodies in wildlife animals in Germany.

Authors:  Susan Mouchantat; Kerstin Wernike; Walburga Lutz; Bernd Hoffmann; Rainer G Ulrich; Konstantin Börner; Ulrich Wittstatt; Martin Beer
Journal:  Vet Res       Date:  2015-09-23       Impact factor: 3.683

4.  Schmallenberg virus in Germany 2011-2014: searching for the vectors.

Authors:  Daniela Kameke; Doreen Werner; Bernd Hoffmann; Walburga Lutz; Helge Kampen
Journal:  Parasitol Res       Date:  2016-02       Impact factor: 2.289

5.  Persistence of the protective immunity and kinetics of the isotype specific antibody response against the viral nucleocapsid protein after experimental Schmallenberg virus infection of sheep.

Authors:  Antoine Poskin; Stephanie Verite; Loic Comtet; Yves Van der Stede; Brigitte Cay; Nick De Regge
Journal:  Vet Res       Date:  2015-10-15       Impact factor: 3.683

6.  A freedom from disease study: Schmallenberg virus in the south of England in 2015.

Authors:  Jessica Eleanor Stokes; Matthew Baylis; Jennifer Sarah Duncan
Journal:  Vet Rec       Date:  2016-10-11       Impact factor: 2.695

7.  The N-terminal domain of Schmallenberg virus envelope protein Gc is highly immunogenic and can provide protection from infection.

Authors:  Kerstin Wernike; Andrea Aebischer; Gleyder Roman-Sosa; Martin Beer
Journal:  Sci Rep       Date:  2017-02-13       Impact factor: 4.379

8.  Post-epidemic Schmallenberg virus circulation: parallel bovine serological and Culicoides virological surveillance studies in Ireland.

Authors:  Á B Collins; D Barrett; M L Doherty; M Larska; J F Mee
Journal:  BMC Vet Res       Date:  2016-10-18       Impact factor: 2.741

9.  Serological testing of Schmallenberg virus in Swedish wild cervids from 2012 to 2016.

Authors:  A Malmsten; J Malmsten; G Blomqvist; K Näslund; C Vernersson; S Hägglund; A-M Dalin; E O Ågren; J-F Valarcher
Journal:  BMC Vet Res       Date:  2017-04-04       Impact factor: 2.741

10.  Development of a Modular Vaccine Platform for Multimeric Antigen Display Using an Orthobunyavirus Model.

Authors:  Andrea Aebischer; Kerstin Wernike; Patricia König; Kati Franzke; Paul J Wichgers Schreur; Jeroen Kortekaas; Marika Vitikainen; Marilyn Wiebe; Markku Saloheimo; Ronen Tchelet; Jean-Christophe Audonnet; Martin Beer
Journal:  Vaccines (Basel)       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.